百心安-B(02185)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02185 百心安-B

已收盘 04-22 16:08:12

2.280

+0.140

+6.54%

最高2.360	最低2.160	成交量43.00万
今开2.170	昨收2.140	日振幅9.35%
总市值5.56亿	流通市值5.38亿	总股本2.44亿
成交额97.20万	换手率0.18%	流通股本2.36亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02185","market":"HK","secType":"STK","nameCN":"百心安-B","latestPrice":2.28,"timestamp":1745309292014,"preClose":2.14,"halted":0,"volume":430000,"delay":0,"floatShares":236000000,"shares":243937000,"eps":-0.3832075562339506,"marketStatus":"已收盘","change":0.14,"latestTime":"04-22 16:08:12","open":2.17,"high":2.36,"low":2.16,"amount":972032,"amplitude":0.093458,"askPrice":2.31,"askSize":14000,"bidPrice":2.28,"bidSize":19800,"shortable":0,"etf":0,"ttmEps":-0.3832075562339506,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1745371800000},"marketStatusCode":5,"adr":0,"listingDate":1640188800000,"exchange":"SEHK","adjPreClose":2.14,"openAndCloseTimeList":[[1745285400000,1745294400000],[1745298000000,1745308800000]],"volumeRatio":11.546724,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02185","defaultTab":"news","newsList":[{"id":"2527230615","title":"百心安-B盘中异动 下午盘快速跳水5.02%报2.080港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527230615","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527230615?lang=zh_cn&edition=full","pubTime":"2025-04-16 14:28","pubTimestamp":1744784927,"startTime":"0","endTime":"0","summary":"2025年04月16日下午盘14时28分，百心安-B股票出现波动，股价急速下跌5.02%。百心安-B股票所在的医疗设备及用品行业中，整体跌幅为0.26%。消息层面，截至14时28分，《百心安-B出资4570万元成立浙江百心安医疗器械有限公司，持股54.68%》资讯为影响百心安-B的重要信息。该信息摘要如下：天眼查工商信息显示，近日，上海百心安生物技术股份有限公司出资4570万元成立浙江百心安医疗器械有限公司，持股54.68%，所属行业为研究和试验发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041614284794d70cd9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041614284794d70cd9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02185","BK1100"],"gpt_icon":0},{"id":"2527561089","title":"百心安-B出资4570万元成立浙江百心安医疗器械有限公司，持股54.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527561089","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527561089?lang=zh_cn&edition=full","pubTime":"2025-04-13 14:09","pubTimestamp":1744524549,"startTime":"0","endTime":"0","summary":"天眼查工商信息显示，近日，上海百心安生物技术股份有限公司出资4570万元成立浙江百心安医疗器械有限公司，持股54.68%，所属行业为研究和试验发展。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/13140949511429.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02185","159883","BK1583","09997","BK1574","BK1222","09996","BK1100"],"gpt_icon":0},{"id":"2518269458","title":"百心安-B盘中异动 股价大跌5.28%报2.510港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518269458","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518269458?lang=zh_cn&edition=full","pubTime":"2025-03-10 11:29","pubTimestamp":1741577350,"startTime":"0","endTime":"0","summary":"2025年03月10日早盘11时29分，百心安-B股票出现异动，股价大幅跳水5.28%。截至发稿，该股报2.510港元/股，成交量40.01万股，换手率0.17%，振幅9.81%。资金方面，该股资金流入17.7966万港元，流出83.1855万港元。百心安-B股票所在的医疗设备及用品行业中，整体跌幅为0.03%。其相关个股中，巨星医疗控股、微泰医疗-B、紫元元涨幅较大，振幅较大的相关个股有高视医疗、心泰医疗、鹰瞳科技-B，振幅分别为22.99%、14.21%、12.95%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310112910a2694a09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310112910a2694a09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1100","02185"],"gpt_icon":0},{"id":"2517144610","title":"百心安-B盘中异动 早盘急速上涨5.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517144610","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517144610?lang=zh_cn&edition=full","pubTime":"2025-03-07 10:11","pubTimestamp":1741313474,"startTime":"0","endTime":"0","summary":"2025年03月07日早盘10时11分，百心安-B股票出现波动，股价快速拉升5.65%。截至发稿，该股报2.430港元/股，成交量23.77万股，换手率0.10%，振幅5.65%。百心安-B股票所在的医疗设备及用品行业中，整体跌幅为0.03%。其相关个股中，百心安-B、心通医疗-B、巨星医疗控股涨幅较大，振幅较大的相关个股有微创机器人-B、心通医疗-B、百心安-B，振幅分别为8.69%、7.20%、5.65%。百心安-B公司简介：上海百心安生物技术有限公司是一家主要从事介入医疗的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307101115a2634573&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307101115a2634573&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02185","BK1100"],"gpt_icon":0},{"id":"2517136741","title":"百心安-B03月06日主力净流入14万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2517136741","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517136741?lang=zh_cn&edition=full","pubTime":"2025-03-06 16:16","pubTimestamp":1741248997,"startTime":"0","endTime":"0","summary":"03月06日, 百心安-B股价涨7.98%，报收2.30元，成交金额218万元，换手率0.41%，振幅11.74%，量比0.69。百心安-B今日主力资金净流入14万元，上一交易日主力净流出70万元。该股近5个交易日上涨12.75%，主力资金累计净流出73万元；近20日主力资金累计净流出317万元，其中净流出天数为7日。该股主力净额占比0.03%，港股市场排名312/2651。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306165845a2622ad6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306165845a2622ad6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02185","BK1100"],"gpt_icon":0},{"id":"2517906394","title":"百心安-B盘中异动 大幅上涨5.16%报2.240港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517906394","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517906394?lang=zh_cn&edition=full","pubTime":"2025-03-06 11:03","pubTimestamp":1741230237,"startTime":"0","endTime":"0","summary":"2025年03月06日早盘11时03分，百心安-B股票出现异动，股价急速上涨5.16%。截至发稿，该股报2.240港元/股，成交量37.21万股，换手率0.16%，振幅5.16%。资金方面，该股资金流入64.0592万港元，流出16.7797万港元。百心安-B股票所在的医疗设备及用品行业中，整体涨幅为0.11%。其相关个股中，心通医疗-B、沛嘉医疗-B、归创通桥-B涨幅较大，振幅较大的相关个股有心通医疗-B、沛嘉医疗-B、GUANZE MEDICAL，振幅分别为13.86%、10.79%、8.82%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306110357989dfb3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306110357989dfb3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02185","BK1100"],"gpt_icon":0},{"id":"2517684995","title":"百心安-B03月05日主力净流出70万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2517684995","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517684995?lang=zh_cn&edition=full","pubTime":"2025-03-05 16:15","pubTimestamp":1741162542,"startTime":"0","endTime":"0","summary":"03月05日, 百心安-B股价跌2.74%，报收2.13元，成交金额241万元，换手率0.49%，振幅15.07%，量比0.95。百心安-B今日主力资金净流出70万元，上一交易日主力净流出0万元。该股近5个交易日上涨12.11%，主力资金累计净流出293万元；近20日主力资金累计净流出332万元，其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305165928a26058ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305165928a26058ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1100","02185"],"gpt_icon":0},{"id":"2517156950","title":"百心安-B盘中异动 下午盘股价大跌6.85%报2.040港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517156950","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517156950?lang=zh_cn&edition=full","pubTime":"2025-03-05 14:01","pubTimestamp":1741154506,"startTime":"0","endTime":"0","summary":"2025年03月05日下午盘14时01分，百心安-B股票出现异动，股价大幅下跌6.85%。截至发稿，该股报2.040港元/股，成交量40.08万股，换手率0.17%，振幅13.24%。资金方面，该股资金流入12.6339万港元，流出60.3418万港元。百心安-B股票所在的医疗设备及用品行业中，整体涨幅为0.02%。其相关个股中，君百延集团、润迈德-B、复锐医疗科技涨幅较大，振幅较大的相关个股有百心安-B、GUANZE MEDICAL、健世科技-B，振幅分别为10.96%、10.45%、9.88%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305140146963a4203&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305140146963a4203&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02185","BK1100"],"gpt_icon":0},{"id":"2516340613","title":"百心安-B现涨逾19% 附属研发的Iberis®RDN系统在德国完成首例商业化手术","url":"https://stock-news.laohu8.com/highlight/detail?id=2516340613","media":"新浪港股","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516340613?lang=zh_cn&edition=full","pubTime":"2025-03-04 11:28","pubTimestamp":1741058880,"startTime":"0","endTime":"0","summary":"　　百心安-B早盘一度涨超21%，截至发稿，股价现涨18.82%，报2.21港元，成交额101.54万港元。　　消息面上，3月3日，百心安-B发布公告，于2025年2月，该公司附属公司上海安通医疗科技有限公司（安通）研发的Iberis多极肾动脉射频消融系统在德国完成首例商业化手术。该手术由University Hospital of Saarland的Saarraaken Kulenthiran博士所领导的团队进行。概无有关并发症或不良事件的报导。该案例得到柏盛国际集团有限公司（柏盛）及安通的共同支持。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-03-04/doc-inenncvt5569400.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["RDN","BK4229","02185","LU0154245673.USD","BK4195","BK1100","LU0154245756.USD"],"gpt_icon":0},{"id":"2516904826","title":"港股异动 | 百心安-B(02185)早盘涨超21% 附属研发的Iberis®RDN系统在德国完成首例商业化手术","url":"https://stock-news.laohu8.com/highlight/detail?id=2516904826","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516904826?lang=zh_cn&edition=full","pubTime":"2025-03-04 10:54","pubTimestamp":1741056888,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，百心安-B早盘涨超21%，截至发稿，涨21.51%，报2.26港元，成交额91.5万港元。消息面上，3月3日，百心安-B发布公告，于2025年2月，该公司附属公司上海安通医疗科技有限公司(安通)研发的Iberis多极肾动脉射频消融系统在德国完成首例商业化手术。公司的最终目标是为全球患者提供门诊RDN手术。安通已于2016年于欧洲取得IberisRDN系统的CE标志，并正在进行一项上市后临床试验，即“RADIUS-HTN”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1257334.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4195","RDN","BK1100","02185","BK4229","LU0154245756.USD","LU0154245673.USD"],"gpt_icon":0},{"id":"2516969102","title":"百心安-B盘中异动 早盘急速上涨8.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516969102","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516969102?lang=zh_cn&edition=full","pubTime":"2025-03-04 09:33","pubTimestamp":1741051989,"startTime":"0","endTime":"0","summary":"2025年03月04日早盘09时33分，百心安-B股票出现波动，股价急速上涨8.60%。百心安-B股票所在的医疗设备及用品行业中，整体涨幅为0.02%。其相关个股中，紫元元、百心安-B、微创机器人-B涨幅较大，振幅较大的相关个股有微创机器人-B、微创医疗、威高股份，振幅分别为6.30%、3.66%、3.64%。百心安-B公司简介：上海百心安生物技术有限公司是一家主要从事介入医疗的中国公司。该公司的产品主要用于满足治疗冠状、外周动脉疾病及高血压等的医疗需求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304093309989ab7e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304093309989ab7e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02185","BK1100"],"gpt_icon":0},{"id":"2516691291","title":"百心安附属公司成功完成首例Iberis多极肾动脉商业化手术","url":"https://stock-news.laohu8.com/highlight/detail?id=2516691291","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516691291?lang=zh_cn&edition=full","pubTime":"2025-03-04 09:31","pubTimestamp":1741051904,"startTime":"0","endTime":"0","summary":"3月4日，百心安-B（02185）发布公告，公司的附属公司安通于2025年2月在德国成功完成Iberis?多极肾动脉射频消融系统的首例商业化手术。该手术由Saarland大学医院的Kulenthiran博士主导，且未报告任何并发症或不良事件。该系统得到了柏盛国际集团的支持，柏盛认为该系统提供了一种更小侵入性、符合人体工学且有效的治疗方式。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503043335653378.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02185","BK1100"],"gpt_icon":0},{"id":"2516680669","title":"百心安-B(02185)附属研发的Iberis®多极肾动脉射频消融系统在德国完成首例商业化手术","url":"https://stock-news.laohu8.com/highlight/detail?id=2516680669","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516680669?lang=zh_cn&edition=full","pubTime":"2025-03-03 20:11","pubTimestamp":1741003890,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百心安-B 公布，于2025年2月，该公司附属公司上海安通医疗科技有限公司(安通)研发的Iberis多极肾动脉射频消融系统在德国完成首例商业化手术。截至本公告日期，IberisRDN系统是全球唯一获准使用经桡动脉方法和经股动脉入路方法的肾神经阻断产品。公司的最终目标是为全球患者提供门诊RDN手术。安通已于2016年于欧洲取得IberisRDN系统的CE标志，并正在进行一项上市后临床试验，即“RADIUS-HTN”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1257130.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02185","BK1100"],"gpt_icon":0},{"id":"2516843577","title":"百心安-B盘中异动 下午盘急速拉升6.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516843577","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516843577?lang=zh_cn&edition=full","pubTime":"2025-03-03 13:53","pubTimestamp":1740981227,"startTime":"0","endTime":"0","summary":"2025年03月03日下午盘13时53分，百心安-B股票出现波动，股价快速拉升6.21%。百心安-B股票所在的医疗设备及用品行业中，整体跌幅为0.17%。其相关个股中，心通医疗-B、百心安-B、巨星医疗控股涨幅较大，振幅较大的相关个股有心通医疗-B、HKE HOLDINGS、微创机器人-B，振幅分别为10.99%、10.69%、8.03%。百心安-B公司简介：上海百心安生物技术有限公司是一家主要从事介入医疗的中国公司。该公司的产品主要用于满足治疗冠状、外周动脉疾病及高血压等的医疗需求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303135347abe57eaa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303135347abe57eaa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1100","02185"],"gpt_icon":0},{"id":"2514366644","title":"百心安-B盘中异动 早盘急速跳水6.37%报1.910港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514366644","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514366644?lang=zh_cn&edition=full","pubTime":"2025-02-28 09:40","pubTimestamp":1740706846,"startTime":"0","endTime":"0","summary":"2025年02月28日早盘09时40分，百心安-B股票出现波动，股价大幅下跌6.37%。截至发稿，该股报1.910港元/股，成交量4.23万股，换手率0.02%，振幅4.41%。资金方面，该股资金流入0港元，流出6.35万港元。百心安-B股票所在的医疗设备及用品行业中，整体跌幅为0.03%。其相关个股中，紫元元、微泰医疗-B、瑛泰医疗涨幅较大，振幅较大的相关个股有微创机器人-B、先健科技、微创医疗，振幅分别为6.83%、5.06%、4.40%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228094046a25715d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228094046a25715d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1100","02185"],"gpt_icon":0},{"id":"2514179608","title":"百心安-B早盘大涨逾31% 国家药监局批准IBERIS®RDN系统注册","url":"https://stock-news.laohu8.com/highlight/detail?id=2514179608","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514179608?lang=zh_cn&edition=full","pubTime":"2025-02-27 11:11","pubTimestamp":1740625860,"startTime":"0","endTime":"0","summary":"　　百心安-B早盘大涨超31%，截至发稿，股价上涨30.53%，现报2.48港元，成交额331.97万港元。　　百心安公布，2月26日，公司附属公司上海安通医疗科技有限公司研发的Iberis多极肾动脉射频消融系统，已获中国国家药品监督管理局批准，用于辅助治疗难治性高血压及药物不耐受的高血压患者。　　德邦证券此前研报指出，Iberis 为全球唯一可以提供两种介入方式的肾动脉消融产品，且具备较细的导管鞘尺寸，有望凭借先发优势和强有力的产品性能迅速抢占市场。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-02-27/doc-inemwuek7213572.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02185","BK1100","LU0154245673.USD","BK4229","RDN","LU0154245756.USD","BK4195"],"gpt_icon":0},{"id":"2514814773","title":"港股异动 | 百心安-B(02185)大涨超31% 国家药监局批准IBERIS®RDN系统注册","url":"https://stock-news.laohu8.com/highlight/detail?id=2514814773","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514814773?lang=zh_cn&edition=full","pubTime":"2025-02-27 10:42","pubTimestamp":1740624166,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，百心安-B(02185)大涨超31%，截至发稿，涨31.58%，报2.5港元，成交额302.21万港元。消息面上，百心安公布，2月26日，公司附属公司上海安通医疗科技有限公司研发的Iberis®多极肾动脉射频消融系统(包括一次性使用多极肾动脉射频消融导管及肾动脉射频消融仪)(Iberis®RDN系统)，已获中国国家药品监督管理局批准，用于辅助治疗难治性高血压及药物不耐受的高血压患者。德邦证券此前研报指出，Iberis 为全球唯一可以提供两种介入方式的肾动脉消融产品，且具备较细的导管鞘尺寸，有望凭借先发优势和强有力的产品性能迅速抢占市场。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1255073.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0154245673.USD","LU0154245756.USD","RDN","02185","BK1100","BK4195","BK4229"],"gpt_icon":0},{"id":"2514281639","title":"百心安-B股价上涨14.74% 市值涨9790.23万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514281639","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514281639?lang=zh_cn&edition=full","pubTime":"2025-02-27 09:30","pubTimestamp":1740619828,"startTime":"0","endTime":"0","summary":"2025年02月27日早盘09时30分，百心安-B股票出现波动，股价大幅拉升14.74%。截至发稿，该股报2.180港元/股，成交量2.42万股，换手率0.01%，振幅8.95%。资金方面，该股资金流入2.405万港元，流出1547港元。百心安-B股票所在的医疗设备及用品行业中，整体涨幅为0.17%。其相关个股中，百心安-B、瑛泰医疗、心通医疗-B涨幅较大，振幅较大的相关个股有百心安-B、微创机器人-B、威高股份，振幅分别为6.84%、3.44%、2.23%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022709302898942f36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022709302898942f36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02185","BK1100"],"gpt_icon":0},{"id":"2514992889","title":"【百心安-B(02185.HK)：国家药监局批准IBERIS®RDN系统注册】百心安-B(02185.HK)发布公告，于2025年2月26日，公司附属公司上海安通医疗科技有限公司(安通)研发的Iberis®多极肾动脉射频消融系统(包括一次性使用多极肾动脉射频消融导管及肾动脉射频消融仪)(Iberis®RDN系统)，已获中国国家药品监督管理局批准，用于辅助治疗难治性高血压及药物不耐受的高血压患者。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514992889","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514992889?lang=zh_cn&edition=full","pubTime":"2025-02-26 17:11","pubTimestamp":1740561096,"startTime":"0","endTime":"0","summary":"百心安-B(02185.HK)发布公告，于2025年2月26日，公司附属公司上海安通医疗科技有限公司(安通)研发的Iberis®多极肾动脉射频消融系统(包括一次性使用多极肾动脉射频消融导管及肾动脉射频消融仪)(Iberis®RDN系统)，已获中国国家药品监督管理局批准，用于辅助治疗难治性高血压及药物不耐受的高血压患者。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/26171148403723.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU0154245673.USD","BK4195","LU0154245756.USD","BK1100","BK4229","RDN","02185","159891"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bio-heart.com","stockEarnings":[{"period":"1week","weight":0.07},{"period":"1month","weight":-0.3206},{"period":"3month","weight":0.4267},{"period":"6month","weight":0.2022},{"period":"1year","weight":0.0594},{"period":"ytd","weight":0.3049}],"compareEarnings":[{"period":"1week","weight":0.0345},{"period":"1month","weight":-0.1352},{"period":"3month","weight":0.0925},{"period":"6month","weight":0.0284},{"period":"1year","weight":0.3165},{"period":"ytd","weight":0.0666}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"上海百心安生物技术股份有限公司是一家主要从事介入医疗业务的中国公司。该公司的主营业务是介入式心血管装置的研发和生产。该公司的主要产品包括全降解支架（BRS）和肾神经阻断（RDN）。该公司的产品主要用于满足治疗冠状、外周动脉疾病及高血压等的医疗需求。该公司的产品主要用于解决中国患者在治疗冠状动脉疾病方面的未满足医疗需求，以及解决患者在治疗未控高血压方面的未满足医疗需求。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.037442},{"month":2,"riseRate":0.25,"avgChangeRate":0.033464},{"month":3,"riseRate":0.5,"avgChangeRate":0.056757},{"month":4,"riseRate":0.5,"avgChangeRate":0.094405},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.068388},{"month":6,"riseRate":0.666667,"avgChangeRate":0.031003},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.045373},{"month":8,"riseRate":0,"avgChangeRate":-0.109703},{"month":9,"riseRate":0.333333,"avgChangeRate":0.003951},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.034879},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.14896},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.262174}],"exchange":"SEHK","name":"百心安-B","nameEN":"BIOHEART-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百心安-B(02185)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百心安-B(02185)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百心安-B,02185,百心安-B股票,百心安-B股票老虎,百心安-B股票老虎国际,百心安-B行情,百心安-B股票行情,百心安-B股价,百心安-B股市,百心安-B股票价格,百心安-B股票交易,百心安-B股票购买,百心安-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百心安-B(02185)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百心安-B(02185)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}